1. Home
  2. SPOK vs PMI Comparison

SPOK vs PMI Comparison

Compare SPOK & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$10.63

Market Cap

220.6M

ML Signal

HOLD

PMI

Picard Medical Inc.

HOLD

Current Price

$0.15

Market Cap

14.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
PMI
Founded
2004
1981
Country
United States
United States
Employees
415
75
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
220.6M
14.1M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
SPOK
PMI
Price
$10.63
$0.15
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
171.3K
13.2M
Earning Date
04-29-2026
06-18-2026
Dividend Yield
11.31%
N/A
EPS Growth
2.74
N/A
EPS
0.09
N/A
Revenue
$139,708,000.00
N/A
Revenue This Year
$1.70
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$117.00
N/A
Revenue Growth
1.49
N/A
52 Week Low
$9.95
$0.11
52 Week High
$19.31
$13.68

Technical Indicators

Market Signals
Indicator
SPOK
PMI
Relative Strength Index (RSI) 40.16 20.71
Support Level $9.95 N/A
Resistance Level $11.55 $0.27
Average True Range (ATR) 0.22 0.03
MACD -0.01 0.03
Stochastic Oscillator 29.86 24.65

Price Performance

Historical Comparison
SPOK
PMI

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.

Share on Social Networks: